Author
Listed:
- Giulia Chiara
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
University of Milan
Università degli Studi di Milano)
- Federica Gervasoni
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
University of Milan
Università degli Studi di Milano)
- Michaela Fakiola
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Chiara Godano
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
University of Milan
Università degli Studi di Milano)
- Claudia D’Oria
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
University of Milan
Università degli Studi di Milano)
- Luca Azzolin
(University of Padua)
- Raoul Jean Pierre Bonnal
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Giulia Moreni
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
Amsterdam University Medical Center, University of Amsterdam)
- Lorenzo Drufuca
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Grazisa Rossetti
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Valeria Ranzani
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Ramona Bason
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
Università degli Studi di Milano)
- Marco Simone
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
University of California)
- Francesco Panariello
(Università degli Studi di Milano
Telethon Institute of Genetics and Medicine TIGEM)
- Ivan Ferrari
(Università degli Studi di Milano)
- Tanya Fabbris
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Francesca Zanconato
(University of Padua)
- Mattia Forcato
(University of Modena and Reggio Emilia)
- Oriana Romano
(University of Modena and Reggio Emilia)
- Jimmy Caroli
(University of Modena and Reggio Emilia)
- Paola Gruarin
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Maria Lucia Sarnicola
(Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’)
- Michelangelo Cordenonsi
(University of Padua)
- Alberto Bardelli
(FPO - IRCCS
University of Torino)
- Nicola Zucchini
(San Gerardo Hospital)
- Andrea Pisani Ceretti
(UO Chirurgia Epatobiliopancreatica e Digestiva Ospedale San Paolo)
- Nicolò Maria Mariani
(UO Chirurgia Epatobiliopancreatica e Digestiva Ospedale San Paolo)
- Andrea Cassingena
(Grande Ospedale Metropolitano Niguarda)
- Andrea Sartore-Bianchi
(Grande Ospedale Metropolitano Niguarda
University of Milan)
- Giuseppe Testa
(University of Milan
University of Milan
European Institute of Oncology, IRCCS)
- Luca Gianotti
(Milano-Bicocca University, and Department of Surgery, San Gerardo Hospital)
- Enrico Opocher
(UO Chirurgia Epatobiliopancreatica e Digestiva Ospedale San Paolo
Università degli Studi di Milano)
- Federica Pisati
(Histopathology Unit, Cogentech)
- Claudio Tripodo
(University of Palermo
IFOM, FIRC Institute of Molecular Oncology)
- Giuseppe Macino
(La Sapienza University of Rome)
- Salvatore Siena
(Grande Ospedale Metropolitano Niguarda
University of Milan)
- Silvio Bicciato
(University of Modena and Reggio Emilia)
- Stefano Piccolo
(IFOM, the FIRC Institute of Molecular Oncology
University of Padua)
- Massimiliano Pagani
(IFOM, the FIRC Institute of Molecular Oncology
Istituto Nazionale Genetica Molecolare INGM ‘Romeo ed Enrica Invernizzi’
University of Milan
Università degli Studi di Milano)
Abstract
Cancer is characterized by pervasive epigenetic alterations with enhancer dysfunction orchestrating the aberrant cancer transcriptional programs and transcriptional dependencies. Here, we epigenetically characterize human colorectal cancer (CRC) using de novo chromatin state discovery on a library of different patient-derived organoids. By exploring this resource, we unveil a tumor-specific deregulated enhancerome that is cancer cell-intrinsic and independent of interpatient heterogeneity. We show that the transcriptional coactivators YAP/TAZ act as key regulators of the conserved CRC gained enhancers. The same YAP/TAZ-bound enhancers display active chromatin profiles across diverse human tumors, highlighting a pan-cancer epigenetic rewiring which at single-cell level distinguishes malignant from normal cell populations. YAP/TAZ inhibition in established tumor organoids causes extensive cell death unveiling their essential role in tumor maintenance. This work indicates a common layer of YAP/TAZ-fueled enhancer reprogramming that is key for the cancer cell state and can be exploited for the development of improved therapeutic avenues.
Suggested Citation
Giulia Chiara & Federica Gervasoni & Michaela Fakiola & Chiara Godano & Claudia D’Oria & Luca Azzolin & Raoul Jean Pierre Bonnal & Giulia Moreni & Lorenzo Drufuca & Grazisa Rossetti & Valeria Ranzani , 2021.
"Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ,"
Nature Communications, Nature, vol. 12(1), pages 1-18, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22544-y
DOI: 10.1038/s41467-021-22544-y
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Maura Galimberti & Maria R. Nucera & Vittoria D. Bocchi & Paola Conforti & Elena Vezzoli & Matteo Cereda & Camilla Maffezzini & Raffaele Iennaco & Andrea Scolz & Andrea Falqui & Chiara Cordiglieri & M, 2024.
"Huntington’s disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids,"
Nature Communications, Nature, vol. 15(1), pages 1-19, December.
- Royce W. Zhou & Jia Xu & Tiphaine C. Martin & Alexis L. Zachem & John He & Sait Ozturk & Deniz Demircioglu & Ankita Bansal & Andrew P. Trotta & Bruno Giotti & Berkley Gryder & Yao Shen & Xuewei Wu & S, 2022.
"A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma,"
Nature Communications, Nature, vol. 13(1), pages 1-17, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22544-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.